1. Smith JA, Marker-Hermann E, Colbert RA. Ankylosing spondylitis: pathogenesis of ankylosing spondylitis: current concepts. Best Pract Res Clin Rheumatol. 2006; 20:571–91.
2. Sieper J, Rudwaleit M, Khan MA, Braun J. Ankylosing spondylitis: concepts and epidemiology of spondyloarthritis. Best Pract Res Clin Rheumatol. 2006; 20:401–17.
3. Van der Linden S, Valkenburg HA, Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum. 1984; 27:361–8.
4. Maksymowych WP, Landewe R. Ankylosing spondylitis: imaging in ankylosing spondylitis. Best Pract Res Clin Rheumatol. 2006; 20:507–19.
5. 김태환, 전재범, 심승철, 장대국, 고희관, 정성수 등. 조기 천장골염의 자기공명영상 소견. 대한류마티스학 회지. 1998; l5:221.
6. Lee YH, Hwang JY, Lee J. The clinical usefullness of multidetector computed tomography of the sacroiliac joint for evaluating spondyloarthropathies. Korean J Intern Med. 2007; 22:171–7.
7. Akkoc N, van der Linden S, Khan MA. Ankylosing spondylitis and symptom-modifiying vs disease-modifying therapy. Best Pract Res Clin Rheumatol. 2006; 20:539–57.
8. Clegg DO, Reda DJ, Weisman MH, Blackburn WD, Cush JJ, CannonGW , et al. Comparison of sulfasalazine and placebo in the treatment of ankylosing spondylitis. A Department of Veterans Affairs Cooperative Study. Arthritis Rheum. 1996; 39:2004–12.
Article
9. Brandt J, Marzo-Ortega H, Emery P. Ankylosing spondylitis: new treatment modalities. Best Pract Res Clin Rheumatol. 2006; 20:559–70.
Article
10. Gorman JD, Sack KE, Davis JC Jr. Treatment of ankylosing spondyitis by inhibition of tumor necrosis factor α. N Engl J Med. 2002; 346:1349–56.
11. 백유흠, 염지연, 이학현, 김태종, 배상철, 유대현 등. 국내 강직성척추염 환자를 대상으로 한 infliximab 치 료. 대한류마티스학회지. 2006; 13:279–84.
12. Braun J, Brandt J, Listing J, Zink A, Alten R, Golder W, et al. Treatment of active ankylosing spondylitis with infliximab: a randomized controlled multicentre trial. Lancet. 2002; 359:1187–93.
13. van der Heijde D, Dijkmans B, Geusens P, Sieper J, DeWoody K, Williamson P, et al. Efficacy and safety of infliximab in patients with ankylosing spondylitis: results of a randomized, placebocontrolled trial (AS SERT). Arthritis Rheum. 2005; 52:582–91.
14. Davis JC, van der Heijde D, Braun J, Dougados M, Cush J, Clegg DO, et al. Recombinant human tumor necrosis factor (etanercept) for treating ankylosing spondylitis: a randomized, controlled trial trial. Arthritis Rheum. 2003; 48:3230–6.
15. van der Heijde D, Kivitz A, Schiff MH, Sieper J, Dijkmans BA, Braun J, et al. Efficacy and safety of adalimumab in patients with ankylosing spondylitis: results of a multicenter, randomized, double-blind, placebocontrolled trial. Arthritis Rheum. 2006; 54:2136–46.
Article
16. Baraliakos X, Davis J, Tsuji W, Braun J. Magnetic resonance imaging examinations of the spine in patients with ankylosing spondylitis before and after therapy with the tumor necrosis factor αreceptor fusion protein etanercept. Arthritis Rheum. 2005; 52:1216–23.
17. Braun J, Landewe R, Hermann KG, Han J, Yan S, Williamson P, et al. Major reduction in spinal inflammation in patients with ankylosing spondlyitis after treatment with infliximab. Arthritis Rheum. 2006; 54:1646–52.
18. Baraliakos X, Barndt J, Listing J, Haibel H, Sorensen H, Rudwaleit M, et al. Outcome of patients with active ankylosing spondlylitis after two years of therapy with etanercept: clinical and magnetic resonance imaging data. Arthritis Rheum. 2005; 53:856–63.
19. Rudwaleit M, Baraliakos X, Listing J, Brandt J, Sieper J, Braun J. Magnetic resonance imaging of the spine and the sacroiliac joints in ankylosing spondylitis and undifferentiated spondyloarthritis during treatment with etanercept. Ann Rheum Dis. 2005; 64:1305–10.
Article
20. Lambert RG, Salonen D, Rahman P, Inman RD, Wong RL, Einstein SG, et al. Adalimumab significantly reduces both spinal and sacroiliac joint inflammation in patients with ankylosing spondylitis. Arthritis Rheum. 2007; 56:4005–14.
21. Baraliakos X, Hermann KG, Landewe R, Listing J, Golder W, Brandt J, et al. Assessment of acute spinal inflammation in patients with ankylosing spondylitis by magnetic resonance imaging: a comparison between contrast enhanced T1 and short tau inversion recovery (STIR) sequences. Ann Rheum Dis. 2005; 64:1141–4.
Article
22. Perry D, Stewart N, Benton N, Robinson E, Yeoman S, Crabbe J, et al. Detection of erosions in the rheumatoid hand; a comparative study of multidetector computerized tomography versus magnetic resonance scanning. J Rheumatol. 2005; 32:256–67.
23. Maksymowych WP, Inman RD, Salonen D, Dhillon SS, Krishnananthan R, Stone M. Spondyloarthritis Research Consortium of Canada magnetic resonance imaging index for assessment of spinal inflammation in ankylosing spondylitis. Arthritis Rheum. 2005; 53:502–9.
Article